Dyadic International DYAI
NASDAQ DYAI
$0.49 -0.02 (-3.66%)
As of: Sep 10, 2026 · 3:59 PM EDT

Dyadic International (DYAI) Enterprise Value (2017 - 2026)

Dyadic International's (DYAI) quarterly Enterprise Value came in at $21.9 million in Q1 2026, down 34.12% year-over-year from $33.3 million in Q1 2025, and down 3.52% quarter-over-quarter from $22.7 million in Q4 2025.

Analysis

Dyadic International (DYAI) Enterprise Value (2017 - 2026) Analysis & Trends

Dyadic International has disclosed Enterprise Value across 10 years of filings, most recently posting $21.9 million for Q1 2026.

  • In Q1 2026, Enterprise Value fell 34.12% year-over-year to $21.9 million; the TTM figure through Mar 2026 stood at $21.9 million (down 34.12% YoY), while the FY2025 annual figure was $22.7 million, down 47.11% from the prior year.
  • Enterprise Value came in at $21.9 million for Q1 2026 at Dyadic International, down from $22.7 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of $70.6 million in Q2 2022 to a low of -$15.4 billion in Q1 2022.
  • Average Enterprise Value over 5 years is -$870.2 million, with a median of $33.5 million recorded in 2024.
  • Year-over-year, Enterprise Value sank 12479.15% in 2022 and soared 100.26% in 2023.
  • Over 5 years, Enterprise Value stood at $22.5 million in 2022, then soared by 73.95% to $39.1 million in 2023, then climbed by 9.78% to $42.9 million in 2024, then slumped by 47.11% to $22.7 million in 2025, then declined by 3.52% to $21.9 million in 2026.
  • Per Business Quant data, the three most recent Enterprise Value figures were $21.9 million in Q1 2026, $22.7 million in Q4 2025, and $29.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Dyadic International 17.78 Mn 9.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 21.92 Mn
Dec 31, 2025 22.72 Mn
Sep 30, 2025 29.20 Mn
Jun 30, 2025 15.63 Mn
Mar 31, 2025 33.27 Mn
Dec 31, 2024 42.95 Mn
Sep 30, 2024 20.85 Mn
Jun 30, 2024 33.53 Mn
Mar 31, 2024 36.70 Mn
Dec 31, 2023 39.12 Mn
Sep 30, 2023 47.14 Mn
Jun 30, 2023 45.48 Mn
Mar 31, 2023 39.55 Mn
Dec 31, 2022 22.49 Mn
Sep 30, 2022 40.16 Mn
Jun 30, 2022 70.57 Mn
Mar 31, 2022 -15.36 Bn
Dec 31, 2021 107.34 Mn
Sep 30, 2021 133.37 Mn
Jun 30, 2021 75.20 Mn